A 49-year-old man with obesity and elevated liver enzymes is found on ultrasound to have hepatic steatosis. Viral hepatitis serology is negative, and alcohol intake is modest. He has features of metabolic syndrome. According to current guidance, what is the cornerstone of management for his non-alcoholic fatty liver disease (NAFLD)?